Novavax (NVAX) volatility elevated into Resolve trial failed its primary and secondary goals
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Novavax (NVAX) September call option implied volatility is at 190, October is at 215, January is at 138; compared to its 52-week range of 61 to 201 into its Resolve trial failed its primary and secondary goals.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Melco Crown Entertainment (MPEL) volatility elevated, Macau denies report of daily ATM withdrawal limit
- Options with increasing volume: AGN RH SWC DIS MGM SWC SYB FNSR STZ BIIB
- Tableau Software (DATA) December calls active